• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫颈癌和子宫内膜癌的脑转移

Brain Metastases from Uterine Cervical and Endometrial Cancer.

作者信息

Kato Mayumi Kobayashi, Tanase Yasuhito, Uno Masaya, Ishikawa Mitsuya, Kato Tomoyasu

机构信息

Department of Gynecology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

出版信息

Cancers (Basel). 2021 Jan 29;13(3):519. doi: 10.3390/cancers13030519.

DOI:10.3390/cancers13030519
PMID:33572880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7866278/
Abstract

Reports on brain metastases (BMs) from uterine cervical carcinoma (CC) and uterine endometrial carcinoma (EC) have recently increased due to the development of massive databases and improvements in diagnostic procedures. This review separately investigates the prevalence, clinical characteristics, clinical presentation, diagnosis, treatment, and prognosis of BMs from CC and uterine endometrial carcinoma EC. For patients with CC, early-stage disease and poorly differentiated carcinoma lead to BMs, and elderly age, poor performance status, and multiple BMs are listed as poor prognostic factors. Advanced-stage disease and high-grade carcinoma are high-risk factors for BMs from EC, and multiple metastases and extracranial metastases, or unimodal therapies, are possibly factors indicating poor prognosis. There is no "most effective" therapy that has gained consensus for the treatment of BMs. Treatment decisions are based on clinical status, number of the metastases, tumor size, and metastases at distant organs. Surgical resection followed by adjuvant radiotherapy appears to be the best treatment approach to date. Stereotactic ablative radiation therapy has been increasingly associated with good outcomes in preserving cognitive functions. Despite treatment, patients died within 1 year after the BM diagnosis. BMs from uterine cancer remain quite rare, and the current evidence is limited; thus, further studies are needed.

摘要

由于大规模数据库的发展和诊断程序的改进,最近关于子宫颈癌(CC)和子宫内膜癌(EC)脑转移(BMs)的报告有所增加。本综述分别调查了CC和子宫内膜癌EC脑转移的患病率、临床特征、临床表现、诊断、治疗和预后。对于CC患者,早期疾病和低分化癌会导致脑转移,老年、身体状况差和多发脑转移被列为不良预后因素。晚期疾病和高级别癌是EC脑转移的高危因素,多发转移和颅外转移或单一治疗可能是预后不良的因素。目前尚无治疗脑转移的“最有效”疗法获得共识。治疗决策基于临床状况、转移灶数量、肿瘤大小和远处器官转移情况。手术切除后辅助放疗似乎是迄今为止最佳的治疗方法。立体定向消融放疗在保留认知功能方面越来越多地与良好预后相关。尽管进行了治疗,患者在脑转移诊断后1年内死亡。子宫癌脑转移仍然相当罕见,目前证据有限;因此,需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b71a/7866278/aecbcf5e2f56/cancers-13-00519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b71a/7866278/aecbcf5e2f56/cancers-13-00519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b71a/7866278/aecbcf5e2f56/cancers-13-00519-g001.jpg

相似文献

1
Brain Metastases from Uterine Cervical and Endometrial Cancer.子宫颈癌和子宫内膜癌的脑转移
Cancers (Basel). 2021 Jan 29;13(3):519. doi: 10.3390/cancers13030519.
2
Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.伽玛刀治疗肺癌脑转移瘤后生活质量和生存的预测因素:一项前瞻性研究。
J Neurosurg. 2018 Jul;129(1):71-83. doi: 10.3171/2017.2.JNS161659. Epub 2017 Aug 18.
3
Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.骨转移肾细胞癌的预后:来自一个大型癌症中心的经验。
Eur J Cancer. 2019 Jan;107:79-85. doi: 10.1016/j.ejca.2018.10.023. Epub 2018 Dec 11.
4
Outcome appraisal of patients with limited brain metastases (BMs) from non small cell lung cancer (NSCLC) treated with different local therapeutic strategies: a single institute evaluation.不同局部治疗策略治疗非小细胞肺癌(NSCLC)脑转移(BMs)局限患者的疗效评估:单机构评估
Br J Radiol. 2017 Apr;90(1072):20170022. doi: 10.1259/bjr.20170022. Epub 2017 Mar 3.
5
Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.子宫癌肉瘤与3级子宫内膜癌患者的临床病理特征、治疗及预后:一项对比研究
J Gynecol Oncol. 2016 Mar;27(2):e18. doi: 10.3802/jgo.2016.27.e18. Epub 2015 Oct 12.
6
Outcome of uterine clear cell carcinomas compared to endometrioid carcinomas and poorly-differentiated endometrioid carcinomas.与子宫内膜样癌和低分化子宫内膜样癌相比,子宫透明细胞癌的预后。
Eur J Gynaecol Oncol. 2008;29(1):57-60.
7
A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.一项全国性多机构回顾性研究,旨在确定子宫体癌和宫颈癌脑转移患者的预后因素并建立分级预后评估系统。
BMC Cancer. 2017 Jun 2;17(1):397. doi: 10.1186/s12885-017-3358-6.
8
Analysis of prognostic factors and comparison of prognostic index scores in patients with brain metastases after whole-brain radiotherapy.全脑放疗后脑转移瘤患者的预后因素分析及预后指数评分比较
Int J Clin Exp Med. 2014 Dec 15;7(12):5217-25. eCollection 2014.
9
Prognostic factors and long-term survival in surgically treated brain metastases from non-small cell lung cancer.非小细胞肺癌脑转移瘤手术治疗后的预后因素及长期生存情况
Clin Neurol Neurosurg. 2016 Mar;142:72-80. doi: 10.1016/j.clineuro.2016.01.011. Epub 2016 Jan 14.
10
Hepatocellular Carcinoma Brain Metastases: A Single-Institution Experience.肝细胞癌脑转移:单中心经验
World Neurosurg. 2020 Aug;140:e27-e32. doi: 10.1016/j.wneu.2020.03.189. Epub 2020 Apr 11.

引用本文的文献

1
Risk and prognosis for brain metastasis in primary metastatic cervical cancer patients: A population-based study.原发性转移性宫颈癌患者脑转移的风险与预后:一项基于人群的研究。
Open Med (Wars). 2025 Aug 22;20(1):20251165. doi: 10.1515/med-2025-1165. eCollection 2025.
2
Stereotactic radiosurgery for brain metastasis from gynecological cancers: A systematic review.妇科癌症脑转移的立体定向放射外科治疗:一项系统评价。
Neurooncol Adv. 2025 Jun 20;7(1):vdaf106. doi: 10.1093/noajnl/vdaf106. eCollection 2025 Jan-Dec.
3
Brain and scalp metastasis of cervical cancer in a patient with human immunodeficiency virus infection: A case report.

本文引用的文献

1
Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?立体定向消融放疗治疗复发性或转移性妇科癌症:延长生命?
Curr Treat Options Oncol. 2020 Jun 12;21(7):58. doi: 10.1007/s11864-020-00748-6.
2
Brain Metastases From Gynecologic Malignancies: Prevalence and Management.妇科恶性肿瘤脑转移:发生率与处理。
Am J Clin Oncol. 2020 Jun;43(6):418-421. doi: 10.1097/COC.0000000000000689.
3
An Instrument to Guide Physicians when Estimating the Survival of Elderly Patients With Brain Metastasis from Gynecological Cancer.
1例人类免疫缺陷病毒感染患者的宫颈癌脑和头皮转移:病例报告
World J Clin Cases. 2025 Jul 6;13(19):103946. doi: 10.12998/wjcc.v13.i19.103946.
4
Brain Metastases in Gynaecologic Cancer: A Retrospective Cohort Study Evaluating Treatment Outcomes, Prognostic Factors, and Overall Survival.妇科癌症脑转移:一项评估治疗结果、预后因素和总生存期的回顾性队列研究
Curr Oncol. 2024 Nov 28;31(12):7575-7585. doi: 10.3390/curroncol31120558.
5
Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report.二线单药 PD-1/CTLA-4 抑制剂治疗有效宫颈癌多发脑肺转移 1 例报告。
Front Immunol. 2024 Oct 14;15:1434697. doi: 10.3389/fimmu.2024.1434697. eCollection 2024.
6
MECOM and the PRDM gene family in uterine endometrial cancer: bioinformatics and experimental insights into pathogenesis and therapeutic potentials.MECOM 与子宫内膜癌中的 PRDM 基因家族:发病机制和治疗潜力的生物信息学和实验研究。
Mol Med. 2024 Oct 28;30(1):190. doi: 10.1186/s10020-024-00946-0.
7
An unusual case of aggressive endometrial adenocarcinoma metastasis to the clivus: illustrative case.侵袭性子宫内膜腺癌转移至斜坡的罕见病例:病例说明
J Neurosurg Case Lessons. 2024 Oct 28;8(18). doi: 10.3171/CASE24392.
8
Recurrent high grade serous endometrial cancer with brain metastases: Immunotherapy confers improved quality of life and survival.复发性高级别浆液性子宫内膜癌伴脑转移:免疫疗法可改善生活质量并延长生存期。
Gynecol Oncol Rep. 2024 Aug 28;55:101494. doi: 10.1016/j.gore.2024.101494. eCollection 2024 Oct.
9
Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.美国二线复发性或转移性宫颈癌治疗的相关因素:一项回顾性行政索赔分析。
Gynecol Oncol Rep. 2022 Dec 13;44:101121. doi: 10.1016/j.gore.2022.101121. eCollection 2022 Dec.
10
Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.美国二线复发性或转移性宫颈癌治疗的相关因素:一项回顾性行政索赔分析。
Gynecol Oncol Rep. 2022 Nov 5;44(Suppl 1):101101. doi: 10.1016/j.gore.2022.101101. eCollection 2022 Dec.
一种用于指导医生评估妇科癌症脑转移老年患者生存情况的工具。
Anticancer Res. 2020 Apr;40(4):2257-2260. doi: 10.21873/anticanres.14188.
4
Clinicopathological study of organ metastasis in endometrial cancer.子宫内膜癌器官转移的临床病理研究。
Future Oncol. 2020 Apr;16(10):525-540. doi: 10.2217/fon-2020-0017. Epub 2020 Mar 9.
5
Mapping distribution of brain metastases: does the primary tumor matter?脑转移瘤的分布图谱:原发肿瘤重要吗?
J Neurooncol. 2020 Mar;147(1):229-235. doi: 10.1007/s11060-020-03419-6. Epub 2020 Feb 17.
6
Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.全脑放疗联合美金刚治疗脑转移瘤患者时对海马的回避:NRG 肿瘤学 CC001 期临床试验。
J Clin Oncol. 2020 Apr 1;38(10):1019-1029. doi: 10.1200/JCO.19.02767. Epub 2020 Feb 14.
7
Clinical characteristics of CNS metastases from primary gynecologic cancers.原发性妇科癌症中枢神经系统转移的临床特征。
Gynecol Oncol Rep. 2019 Nov 11;30:100518. doi: 10.1016/j.gore.2019.100518. eCollection 2019 Nov.
8
Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.诊断时患有远处转移的卵巢癌、宫颈癌和子宫体癌患者:最常见的转移部位和结局。
Clin Exp Metastasis. 2020 Feb;37(1):107-113. doi: 10.1007/s10585-019-10007-0. Epub 2019 Nov 22.
9
Pathologically confirmed brain metastases from primary uterine cervical tumors: two cases and a literature review.经病理证实的原发性子宫颈肿瘤脑转移:两例病例并文献复习。
World J Surg Oncol. 2019 Oct 31;17(1):174. doi: 10.1186/s12957-019-1720-7.
10
Leptomeningeal metastases arising from gynecological cancers.妇科癌症引起的脑膜转移。
Int J Clin Oncol. 2020 Feb;25(2):391-395. doi: 10.1007/s10147-019-01556-1. Epub 2019 Oct 4.